On the other hand, aromatase inhibitors are the most suitable drugs for inhibiting estrogen biosynthesis in some estrogen-sensitive diseases, such as breast cancer, ovulation disorders, endometriosis, fibroids, or precocious puberty[17-23]. The gene discussed is CYP19A1; the disease is breast carcinoma.